UBS AM’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.94M | Buy |
316,276
+103,324
| +49% | +$959K | ﹤0.01% | 1965 |
|
|
2025
Q1 | $1.56M | Sell |
212,952
-5,636
| -3% | -$41.3K | ﹤0.01% | 2106 |
|
|
2024
Q4 | $1.87M | Buy |
218,588
+70,904
| +48% | +$606K | ﹤0.01% | 2086 |
|
|
2024
Q3 | $1.28M | Sell |
147,684
-38,376
| -21% | -$334K | ﹤0.01% | 2266 |
|
|
2024
Q2 | $1.27M | Buy |
+186,060
| New | +$1.27M | ﹤0.01% | 2250 |
|
|
2022
Q2 | – | Sell |
-101,123
| Closed | -$501K | – | 2743 |
|
|
2022
Q1 | $501K | Buy |
101,123
+22,065
| +28% | +$109K | ﹤0.01% | 2461 |
|
|
2021
Q4 | $551K | Buy |
79,058
+10,437
| +15% | +$72.7K | ﹤0.01% | 2519 |
|
|
2021
Q3 | $686K | Sell |
68,621
-6,599
| -9% | -$66K | ﹤0.01% | 2345 |
|
|
2021
Q2 | $1.07M | Buy |
75,220
+12,772
| +20% | +$181K | ﹤0.01% | 2172 |
|
|
2021
Q1 | $1.02M | Buy |
62,448
+12,311
| +25% | +$202K | ﹤0.01% | 2079 |
|
|
2020
Q4 | $1.04M | Buy |
+50,137
| New | +$1.04M | ﹤0.01% | 1970 |
|